Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides.
about
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseasesPrevention and treatment of biofilms by hybrid- and nanotechnologies.Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing AntibodiesMolecular targets for rapid identification of Brucella spp.Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.Use of aminoglycosides in treatment of infections due to intracellular bacteriaEfficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.Versatility of aminoglycosides and prospects for their future.Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicinSuccessful treatment using gentamicin liposomes of Salmonella dublin infections in mice.Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected miceTherapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes.Preparation and use of liposomes in the treatment of microbial infections.Liposomes in treatment of infectious diseases.Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortusLiposomes in the treatment of infections.Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems.Distribution of free and liposomal cefoxitin in plasma and peritoneal fluid in a porcine intra-abdominal sepsis model.Importance of Biofilms in Urinary Tract Infections: New Therapeutic Approaches
P2860
Q26852693-9CCCB746-6F51-4734-878E-569F4BF0CA94Q27692708-4B630C7A-D972-495C-9ED0-A13F2A242E42Q28551599-CE9D92B2-56CB-4B22-B76E-32468A5515AAQ33234895-C96D1A26-B781-40D2-AF9B-116577C1FAACQ33977208-128A7876-C853-4F27-BC9B-A8AAB3026B48Q33983252-B41479F7-15B1-4E67-BB18-87666730D769Q34057550-C7355EE7-A961-4090-8AC3-00B7E72D2A8BQ35123061-BCB98338-0233-481B-8FA7-E78C73935F1DQ35176271-09E04932-931A-431D-A8F3-933ADE5B86D9Q35248396-B7223A69-F6AF-47F6-A023-59B4745F7802Q35248762-A4B082E4-D455-44A6-95B5-323117CFC7F7Q35654035-89F9DB1B-1B51-4935-BCC5-C229EB6B10F7Q35758804-1F11C0E2-2D71-4D5F-8E7E-44DAF5FD9AF2Q35835303-D010F791-BF36-4DB9-B73C-CDE5016B9917Q39558977-D5227178-1E48-47AD-97E8-90A8AD0DC4E3Q39654122-B665C828-DFFE-48EC-A148-3F157B342901Q39663756-22205E6E-08BD-48CC-B297-D0E2B9352A7CQ39781236-1B2162CF-FC50-4BE2-9636-B6ADCB47CF47Q40499095-8C88DBC7-F5CA-463C-B3E1-C3265C729A96Q40899101-AC1BAFD5-84BF-48D6-B885-59066984880EQ40974806-146CA5EC-D2D5-4407-863F-44F2454CE461Q42684097-9BC5E6FA-74F3-4D7A-9157-7C6F7D611EE8Q59042611-80AA91A1-9BAC-48AF-A4CF-C45BD30BF226
P2860
Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@en
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@nl
type
label
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@en
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@nl
prefLabel
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@en
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@nl
P2093
P356
P1476
Treatment of Brucella canis an ...... -encapsulated aminoglycosides.
@en
P2093
P304
P356
10.1093/INFDIS/152.3.529
P407
P577
1985-09-01T00:00:00Z